TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB – a study protocol

[1]  B. Corleis,et al.  M. tuberculosis-Induced Necrosis of Infected Neutrophils Promotes Bacterial Growth Following Phagocytosis by Macrophages. , 2017, Cell host & microbe.

[2]  D. Mitchison,et al.  Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. , 2015, The American review of respiratory disease.

[3]  Michael Hoelscher,et al.  Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. , 2014, The Lancet. Infectious diseases.

[4]  K. Floyd,et al.  Beyond UHC: Monitoring Health and Social Protection Coverage in the Context of Tuberculosis Care and Prevention , 2014, PLoS medicine.

[5]  Anthony D Harries,et al.  Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice. , 2014, The lancet. Diabetes & endocrinology.

[6]  G. Walzl,et al.  Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputum , 2014, European Respiratory Journal.

[7]  M. Raviglione,et al.  Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review , 2014, European Respiratory Journal.

[8]  A. Ralph,et al.  High Morbidity during Treatment and Residual Pulmonary Disability in Pulmonary Tuberculosis: Under-Recognised Phenomena , 2013, PloS one.

[9]  N. Thomas,et al.  Month 2 Culture Status and Treatment Duration as Predictors of Tuberculosis Relapse Risk in a Meta-Regression Model , 2013, PloS one.

[10]  A. Rathi,et al.  Pulmonary tuberculosis: the day after. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[11]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[12]  T. Bärnighausen,et al.  Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa – a systematic review , 2012, BMC Public Health.

[13]  M. Barer,et al.  Targeting Persisters for Tuberculosis Control , 2012, Antimicrobial Agents and Chemotherapy.

[14]  I. Comas,et al.  A role for systems epidemiology in tuberculosis research. , 2011, Trends in microbiology.

[15]  A. Harries,et al.  The impact of diabetes on tuberculosis treatment outcomes: A systematic review , 2011, BMC medicine.

[16]  R. Ehrlich,et al.  Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studies. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  M. Uplekar,et al.  Tuberculosis and noncommunicable diseases: neglected links and missed opportunities , 2010, European Respiratory Journal.

[18]  Virginia Pascual,et al.  An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.

[19]  C. Dye,et al.  A consistent log-linear relationship between tuberculosis incidence and body mass index. , 2010, International journal of epidemiology.

[20]  C. Parry,et al.  The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review , 2009, BMC public health.

[21]  M. Murray,et al.  Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies , 2008, PLoS medicine.

[22]  G. Churchyard,et al.  Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment , 2000, Thorax.

[23]  Sang-Nae Cho,et al.  Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. , 2010, Chest.